{"entity":{"id":"nct01086605","kind":"trial","name":"Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer","aka":[],"tldr":"A phase 2 trial of Pixantrone in Breast cancer, run by Alliance for Clinical Trials in Oncology, completed.","summary":"Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer is a phase 2 interventional study registered as NCT01086605 by Alliance for Clinical Trials in Oncology, with 46 participants recorded, started 2010-05 and reaching its primary completion in 2012-01. Interventions recorded: pixantrone dimaleate. Conditions recorded: Breast Cancer.\n\nLinked to the drug Pixantrone because the registry names it among its interventions and Breast cancer among its conditions. Registry record only: no result has been read by an editor.","status":"completed","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT01086605","url":"https://clinicaltrials.gov/study/NCT01086605"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["breast-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":["pixantrone"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT01086605","phase":"2","setting":"Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer","sponsor":"Alliance for Clinical Trials in Oncology","enrolled":46,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct01086605/","neighbours":{"cancer":[{"id":"breast-cancer","kind":"cancer","name":"Breast cancer (all types)","route":"/cancers/breast-cancer/"}],"drug":[{"id":"pixantrone","kind":"drug","name":"Pixantrone","route":"/drugs/pixantrone/"}]}}